CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners

Sponsor
Erasmus Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00348751
Collaborator
Dutch Heart Foundation (Other)
1
17

Study Details

Study Description

Brief Summary

Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners.

Condition or Disease Intervention/Treatment Phase
  • Device: CholGate
N/A

Detailed Description

Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners, using a clinical decsion support system called CholGate. This system has the functionality to provide both Alerting and On-Demand decision support. Users are free to negate the advise provided by the decision support system. The trial will have a cluster randomized structure.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners - The CholGate Randomized Trial
Study Start Date :
Jun 1, 2004
Study Completion Date :
Nov 1, 2005

Outcome Measures

Primary Outcome Measures

  1. The percentage of correctly screened patients using anonymous patient record data. []

  2. The percentage of correctly treated patients using anonymous patient record data. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All general practices using only Elias electronic patient records (ISOFT b.V)

  • All patients meeting the screening and treatment criteria of the Dutch college of general practitioners cholesterol guideline

Exclusion Criteria:
  • Practices that used paper based records

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Medical informatics, ErasmusMC Rotterdam South Holland Netherlands 3000DR

Sponsors and Collaborators

  • Erasmus Medical Center
  • Dutch Heart Foundation

Investigators

  • Principal Investigator: Jacobus T van Wyk, MD, PhD, ErasmusMC University Medical Centre Rotterdam

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00348751
Other Study ID Numbers:
  • 2000B161
First Posted:
Jul 6, 2006
Last Update Posted:
May 8, 2008
Last Verified:
Jun 1, 2006
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 8, 2008